I agree the vote is not tied to the trials, but di

I agree the vote is not tied to the trials, but disagree in that it is significantly tied to the finances. We are in the dark of what their future plans are, so to have a vote to increase AS without some sort of explanation of their financial plan is voting blindly. Without such a plan we are essentially saying that it is okay to dilute at these price levels another 100M. I would take this option if it was between this and failure, but would not do so willingly if there were any other viable options even if that means not getting full value for HIV or PCa (anything fair value and above). This is only my thoughts and if they decide fair value is much higher than the offer AND they have a solid alternative plan, then I would support.

I understand they cannot fully disclose and don’t know some things as none of us can predict the future, but we are largely in the dark and speculating on what the financial future looks like. I have faith that management and the BOD is doing their best to secure non-dilutive financing, but to have such a vote before any specifics are known, disclosed or discussed is not a very responsible strategy IMO. I still feel this will be addressed in some way beforehand.

Please do your own due diligence. All my posts and comments are not to be considered investment advice.